Dr. Patrick D. Williams, MD

Dr. Williams practices at Texas Retina Associates in Fort Worth, Texas.

Dr. Williams' NPI, 1154306777, was assigned on December 7, 2005. Dr. Williams graduated from Texas Tech University Health Sciences Center School of Medicine in 2001. Dr. Williams holds Texas license M1405.

Dr. Williams' primary practice is Texas Retina Associates, at 1101 6th Ave, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 261-9625.

Dr. Williams' primary practice is Texas Retina Associates in Fort Worth, Texas. Dr. Williams is also affiliated with UPMC Hamot. Dmand AI also links Dr. Williams to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Williams practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Williams' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Williams is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Williams is licensed in Texas.

Dmand AI lists age-related macular degeneration, cataract, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation, glaucoma and inflammation of iris among the conditions Dr. Williams treats.

CMS data shows 42,658 Medicare services from Dr. Williams across 23 procedure codes in 2024, for 980 Medicare patients. Medicare paid $3,041,889 for them.

CMS counts 980 Medicare patients who saw Dr. Williams in 2024. The largest group is 65 to 74, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Williams' median patient age at 73, with 53% women.

In 2024, Dr. Williams wrote 627 Medicare Part D claims for 286 patients. 72% of them were for generic drugs. CMS names the drug for 536 of them, across 9 drugs with 11 or more claims each, at $18,567 in total drug cost. In 2023, CMS named 495 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Williams for performance year 2024, reported as part of a group. Dr. Williams accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Williams, published from 2011 to 2018. The most frequent topics are Angiogenesis Inhibitors, Bevacizumab and Intravitreal Injections. Dr. Williams has published most often in Retina. Dr. Williams' most frequent co-authors are David G. Callanan, MD, Deborah Y. Chong, MD and Ashkan Michael Abbey, MD.

Dmand AI links Dr. Williams to 1 clinical trial. Open Payments lists research payments to Dr. Williams that name 1 trial.

CMS Open Payments shows 140 general payments to Dr. Williams from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $18,047. It also lists 5 research payments totaling $1,260 in 2016, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Williams, most recently CMS Stage 1 EHR in 2013.

Dr. Williams graduated from Texas Tech University Health Sciences Center School of Medicine in 2001. Dr. Williams is a member of AAO.

Dr. Williams is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.